Neuraxis (NRXS) EPS (Weighted Average and Diluted) (2022 - 2025)
Historic EPS (Weighted Average and Diluted) for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to -$0.24.
- Neuraxis' EPS (Weighted Average and Diluted) rose 400.0% to -$0.24 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0, marking a year-over-year decrease of 16315.79%. This contributed to the annual value of -$1.22 for FY2024, which is 7285.12% up from last year.
- Per Neuraxis' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.24 for Q3 2025, which was up 400.0% from -$0.22 recorded in Q2 2025.
- Neuraxis' 5-year EPS (Weighted Average and Diluted) high stood at $0.61 for Q4 2023, and its period low was -$2.38 during Q3 2023.
- Its 4-year average for EPS (Weighted Average and Diluted) is -$0.59, with a median of -$0.32 in 2024.
- As far as peak fluctuations go, Neuraxis' EPS (Weighted Average and Diluted) soared by 69200.11% in 2023, and later tumbled by 13825.01% in 2024.
- Neuraxis' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.1 in 2022, then skyrocketed by 692.0% to $0.61 in 2023, then tumbled by 138.25% to -$0.23 in 2024, then dropped by 2.86% to -$0.24 in 2025.
- Its last three reported values are -$0.24 in Q3 2025, -$0.22 for Q2 2025, and -$0.33 during Q1 2025.